Michael Dexter

From Wikipedia, the free encyclopedia

Michael Dexter
Painting of Mike Dexter holding a glass of wine.
Mike Dexter. Acrylic painting by Alex Dexter, 2003.
Born
Thomas Michael Dexter

(1945-05-15) 15 May 1945 (age 76)
Alma materUniversity of Salford (BSc)
University of Manchester (PhD)[1]
Known forDirector of Wellcome Trust
Cancer research
AwardsFellow of the Royal Society (1991)[1]
Scientific career
FieldsHaematology
InstitutionsWellcome Trust
University of Manchester
Paterson Institute for Cancer Research
ThesisLeukaemogenesis by the alkylating agent methylnitrosourea (1974)

(Thomas) Michael Dexter FRS (born 15 May 1945)[1] is a British haematologist and director of the Wellcome Trust, from 1998 to 2003.[2][3][4]

Education[]

Dexter was inspired to take A levels at night school[5] and went on study physiology and zoology at the University of Salford. After graduating, he continued in academia and received a PhD from the University of Manchester in 1974 for research into Leukemia.[6] Dexter also received a Doctor of Science degree from the University of Salford in 1982.[1]

Career[]

Dexter was visiting fellow at the Memorial Sloan–Kettering Cancer Center and a professor of haematology at the University of Manchester from 1985 to 1998.[7]

He was director of the Paterson Institute for Cancer Research[8] and the Wellcome Trust.[9] He has authored over author of 360 articles in scientific journals including Nature[10][11][12] and is an editor of four books.[1][13]

Awards and honours[]

Dexter was elected a Fellow of the Royal Society (FRS) in 1991.[1]

References[]

  1. ^ Jump up to: a b c d e f "DEXTER, Dr (Thomas) Michael". Who's Who. ukwhoswho.com. 2016 (online Oxford University Press ed.). A & C Black, an imprint of Bloomsbury Publishing plc. (subscription or UK public library membership required) (subscription required)
  2. ^ Mertl, M. (2002). "Michael Dexter to Step Down at Wellcome Trust". Science. 296 (5567): 453a–. doi:10.1126/science.296.5567.453a. PMID 11964454.
  3. ^ Williams, Nigel (1998). "Michael Dexter takes over Wellcome Trust's pot of gold". Science. 280 (5372): 2043–2044. doi:10.1126/science.280.5372.2043a. PMID 9669957.
  4. ^ Anon (2002). "Wellcome Trust Director announces his retirement". wellcome.ac.uk. London: Wellcome Trust. Archived from the original on 31 January 2010.
  5. ^ "In the news: Mike Dexter". timeshighereducation.co.uk. 18 April 2002. Retrieved 23 June 2016.
  6. ^ Dexter, Thomas Michael (1974). Leukaemogenesis by the alkylating agent methylnitrosourea (PhD thesis). University of Manchester. Archived from the original on 16 June 2013.
  7. ^ "Emeritus Prof Michael Dexter, FRS Authorised Biography – Debrett's People of Today". debretts.com. Retrieved 23 June 2016.
  8. ^ "About Us, history". University of Manchester.
  9. ^ "Archived copy". Archived from the original on 21 June 2013. Retrieved 10 December 2011.CS1 maint: archived copy as title (link)
  10. ^ Dexter, T. M.; White, H. (1990). "Growth without inflation". Nature. 344 (6265): 380–381. doi:10.1038/344380a0. PMID 2320106.
  11. ^ Whetton, A. D.; Dexter, T. M. (1983). "Effect of haematopoietic cell growth factor on intracellular ATP levels". Nature. 303 (5918): 629–631. doi:10.1038/303629a0. PMID 6855907.
  12. ^ Dexter, T. M.; Moore, M. A. (1977). "In vitro duplication and "cure" of haemopoietic defects in genetically anaemic mice". Nature. 269 (5627): 412–414. doi:10.1038/269412a0. PMID 561894.
  13. ^ Dexter, T. Michael; Testa, Nydia G.; Lord, Brian I. (1997). Hematopoietic lineages in health and disease. New York: M. Dekker. ISBN 0-8247-9512-1.
Preceded by
Bridget Ogilvie 		Director of Wellcome Trust
1998–2008 		Succeeded by
Mark Walport
Retrieved from ""